Plasmodium species broad cellular processes

Plasmodium species broad cellular processes refer to the suite of essential biological activities required for the survival and pathogenesis of malaria parasites within the human host. These processes include the detoxification of heme released during hemoglobin digestion, the maintenance of electrochemical gradients, and the synthesis of nucleic acids and proteins necessary for rapid asexual replication in red blood cells [Source: CDC, 2023; PMID: 24035612]. Because these parasites are eukaryotes, many of their cellular processes are distinct from those of the human host, providing a variety of therapeutic windows. Historically, many effective antimalarials were identified through phenotypic screening against the whole parasite, targeting these broad processes before specific molecular receptors were characterized. However, the rapid evolution of resistance mechanisms, such as the PfCRT transporter mutations or K13 propeller mutations, poses a continuous threat to therapies targeting these pathways [Source: Nature, 2015; doi:10.1038/nature16468]. Understanding the breadth of Plasmodium cellular biology remains critical for the development of next-generation combination therapies.

Other names

Plasmodium cellular pathwaysMalaria parasite phenotypic targetsPlasmodium metabolic processesWhole-cell malaria targets

Antimalarial agents target broad cellular processes through several distinct mechanisms: inhibition of hemozoin formation (e.g., quinolines), inhibition of the mitochondrial electron transport chain (e.g., atovaquone), disruption of folate synthesis (e.g., sulfadoxine-pyrimethamine), and the generation of reactive oxygen species that damage parasite membranes and proteins (e.g., artemisinins) [Source: WHO, 2023; PMID: 30545952].